Mersana Therapeutics, Inc. (NASDAQ:MRSN) Sees Large Decline in Short Interest

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) saw a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 8,460,000 shares, a decline of 28.7% from the November 30th total of 11,870,000 shares. Based on an average daily volume of 1,990,000 shares, the short-interest ratio […]

Related Keywords

,Vanguard Group Inc ,Janssen Biotech Inc ,Bellevue Group ,Merck Kgaa ,Citigroup ,Asana Biosciences ,Mersana Therapeutics Inc ,Mersana Therapeutics Company Profile ,Nasdaq ,Blackrock Inc ,Merck Kga ,Mersana Therapeutics ,Get Free Report ,Street Corp ,Janssen Biotech ,Mersana Therapeutics Daily ,Nasdaq Mrsn ,Mrsn ,Medical ,Stocks ,Options ,Put ,Call ,